In breast cancer, low cytoplasmic DHX37 protein expression was significantly associated with adverse clinicopathological parameters including larger tumour size, higher grade, lymphovascular invasion and positive nodal status (all P < 0.001). The gene discussed is DHX37; the disease is breast carcinoma.